Trump Announces Emergency Authorization For Blood Plasma As Treatment For COVID

President Trump announced that a coronavirus treatment that involves blood plasma from people who've recovered from the disease will be expanded to many more sick Americans after the FDA approved use of the therapy.

"Convalescent plasma has been a tried-and-true therapeutic treatment in prior outbreaks," Health and Human Services Secretary Alex Azar said at the news conference, while FDA Commissioner Stephen Hahn said researchers had seen a 35% improvement in patients treated with the convalescent plasma.

Today, the U.S. Food and Drug Administration issued an emergency use authorization for investigational convalescent plasma for the treatment of COVID-19 in hospitalized patients as part of the agency's ongoing efforts to fight COVID-19.

"The Trump Administration recognized the potential of convalescent plasma early on. Months ago, the FDA, BARDA, and private partners began work on making this product available across the country while continuing to evaluate data through clinical trials. Our work on convalescent plasma has delivered broader access to the product than is available in any other country and reached more than 70,000 American patients so far. We are deeply grateful to Americans who have already donated and encourage individuals who have recovered from COVID-19 to consider donating convalescent plasma."

"The FDA has issued an emergency use authorization ... for a treatment known as convalescent plasma. This is a powerful therapy that transfuses very, very strong antibodies from the blood of recovered patients to help treat patients battling a current infection," Trump said.

And instead both Bloomberg and StatNews report that Trump will announce that a new coronavirus treatment involving blood plasma from patients who have recovered from the disease, has received an emergency use authorization from the FDA, which is expected to clear for use with certain patients what's known as convalescent plasma.

Blood plasma is among a host of potential therapeutics that have been undergoing testing in clinical trials, StatNews notes adding that the hope is that infusions of antibody-rich plasma from those who have recovered from Covid-19 can be injected into ill patients, kickstarting their immune system and allowing them to fight off the virus until they can generate their own antibodies.

https://www.zerohedge.com/political/trump-jabs-fda-rejecting-hcq-claims-deep-state-or-whoever-delaying-vaccine-trials